Standing Ovation raises 30M Series B round
Briefly

Standing Ovation raises 30M Series B round
"Standing Ovation has validated industrial-scale production of its Advanced Casein with Bel Group, a strategic partner since 2022, marking a significant milestone in precision fermentation."
"The company’s flagship product, Advanced Casein, is produced through precision fermentation of dairy side-streams, primarily acid whey, which is a byproduct of cheese production."
"Casein constitutes roughly 80% of milk's protein content and is crucial for the texture and functionality of dairy products, making it a valuable target for production."
"Most precision fermentation efforts have focused on whey proteins, but Standing Ovation is targeting casein, which is technically more challenging to produce but offers higher value."
Standing Ovation, a Paris-based startup, has raised €30 million in a Series B funding round to support the commercial rollout of its Advanced Casein product. The funding will facilitate entry into the US market in 2026, followed by Europe and Asia in 2027, pending regulatory approvals. The company focuses on producing casein from dairy waste streams, primarily acid whey, and aims to capitalize on the higher value of casein compared to whey proteins. Total funding to date amounts to approximately €46 million.
Read at TNW | Startups-Technology
Unable to calculate read time
[
|
]